ICU MEDICAL INC/DE Short-Term Debt
ICU MEDICAL INC/DE (ICUI) had Short-Term Debt of $18.75 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:DebtCurrent · last filed 2026-08-06
- 2026-06-30: Debt, Current $18.75M.
- 2026-03-31: Debt, Current $18.75M.
- 2025-12-31: Debt, Current $18.75M.
- 2025-09-30: Debt, Current $0.00.
| Period end | Debt, Current |
|---|---|
| 2026-06-30 | $18.75M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $18.75M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $18.75M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 |
| 2025-03-31 | $47.81M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $51.00M 10-K · filed 2026-02-19 |
| 2024-09-30 | $51.00M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $51.00M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $51.00M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $51.00M 10-K · filed 2025-02-27 |
| 2023-09-30 | $45.69M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $40.38M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $35.06M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $29.69M 10-Q · filed 2023-11-06 |
| 2022-09-30 | $24.38M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $19.06M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $13.81M 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |